Related Experiment Videos
Clinical applications of interleukin-2
1CRC Department of Medical Oncology, Christie Hospital, Manchester, U.K.
Progress in Growth Factor Research
|January 1, 1992
Summary
Interleukin-2 (IL-2) immunotherapy shows significant anticancer effects in preclinical studies. Clinical trials exploring various IL-2 administration methods and combinations are reviewed, highlighting its potential in cancer treatment.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Interleukin-2 (IL-2) is a cytokine with strong immunomodulating properties.
- IL-2 has demonstrated significant antitumour activity in preclinical cancer models.
- Clinical investigations have explored various administration routes and schedules for IL-2.
Purpose of the Study:
- To review published clinical studies on IL-2 based immunotherapy.
- To summarize the findings on IL-2's efficacy in cancer treatment.
- To provide an overview of IL-2's application in clinical settings.
Main Methods:
- Review of published clinical studies involving IL-2 immunotherapy.
- Analysis of IL-2 administration as a single agent or in combination therapies.
- Evaluation of studies using different routes and schedules of IL-2 delivery.
Main Results:
- IL-2 has been investigated in various clinical trial settings.
- Combination therapies include other cytokines, immunomodulating agents, chemotherapy, and cell-based approaches.
- The review synthesizes results from diverse clinical studies on IL-2 based immunotherapy.
Conclusions:
- IL-2 based immunotherapy has been extensively studied in clinical trials.
- Various strategies for IL-2 administration have been explored to optimize its therapeutic effects.
- The reviewed studies provide insights into the clinical application and potential of IL-2 in cancer treatment.